BCIQ Profiles

Company Profile ReportTarget Profile Report
DIST_0803_pnas.2104099118

Enhancing NK cell cancer therapies with bispecific antibodies

Aug 27, 2021 | 9:18 PM GMT

DISEASE CATEGORY: Cancer

INDICATION: B cell lymphoma; breast cancer

Bispecific antibodies targeting both an NK cell activating receptor and a tumor antigen

Read the full 332 word article

How to gain access

Continue reading with a
two-week free trial.